TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states.
Saved in:
| Title: | TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states. |
|---|---|
| Authors: | Panzeri I; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA. ilaria.panzeri@vai.org.; Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. ilaria.panzeri@vai.org., Fagnocchi L; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA., Apostle S; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA., Tompkins M; Vivarium and Transgenics Core, Van Andel Institute, Grand Rapids, MI, USA., Wolfrum E; Bioinformatics and Biostatistics Core, Van Andel Institute, Grand Rapids, MI, USA., Madaj Z; Bioinformatics and Biostatistics Core, Van Andel Institute, Grand Rapids, MI, USA., Hostetter G; Pathology and Biorepository Core, Van Andel Institute, Grand Rapids, MI, USA., Liu Y; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA., Schaefer K; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA., Yang CH; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.; Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA., Bergsma A; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.; Parkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA., Drougard A; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA., Dror E; Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany., Chandler DP; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA., Schramek D; Centre for Molecular and Systems Biology, Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Triche TJ Jr; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.; Department of Pediatrics, MSU College of Human Medicine, East Lansing, MI, USA.; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA., Pospisilik JA; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA. andrew.pospisilik@vai.org.; Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. andrew.pospisilik@vai.org. |
| Corporate Authors: | PERMUTE |
| Source: | Nature cancer [Nat Cancer] 2025 Feb; Vol. 6 (2), pp. 385-403. Date of Electronic Publication: 2025 Jan 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
